Observational Study of Interstitial Glucose Monitoring With Continuous Glucose Monitoring to Track Patients Treated With Exenatide
|ClinicalTrials.gov Identifier: NCT00569907|
Recruitment Status : Completed
First Posted : December 10, 2007
Last Update Posted : November 26, 2015
Approximately 30 adults will participate in this study at the International Diabetes Center (IDC). The IDC is the only site conducting this study.
Length of participation can range from two to three months which will include four to seven clinic visits.
The purpose of this study is to use a Continuous Glucose Monitoring (CGM) system to determine the characteristics of glucose control and patterns of food intake before exenatide is started, during the start and adjustment of exenatide and during exenatide treatment.
The long-term purpose of this study is to determine to what extent continuous glucose monitoring improves or alters clinical decision making for patients treated with exenatide. And, the study will also compare CGM to conventional self-monitored blood glucose methods.
The study will also compare subjects' changes, if any, in nutrient intake such as energy, protein, fat and carbohydrate during the course of the study through interpretation/analysis of self-reported food intake.
|Condition or disease|
|Diabetes Mellitus Type 2|
|Study Type :||Observational|
|Actual Enrollment :||18 participants|
|Official Title:||Observational Study of Interstitial Glucose Monitoring With Continuous Glucose Monitoring to Track Patients Treated With Exenatide|
|Study Start Date :||January 2007|
|Primary Completion Date :||May 2009|
|Study Completion Date :||May 2009|
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00569907
|United States, Minnesota|
|International Diabetes Center - Park Nicollet Health Services|
|Minneapolis, Minnesota, United States, 55416|
|Principal Investigator:||Roger Mazze, PhD||International Diabetes Center - Park Nicollet Institute|
|Principal Investigator:||Robert M. Cuddihy, MD||International Diabetes Center - Park Nicollet Institute|
|Principal Investigator:||Ellie Strock, ANP||International Diabetes Center - Park Nicollet Institute|